Journal of Shandong University (Health Sciences) ›› 2021, Vol. 59 ›› Issue (4): 79-86.doi: 10.6040/j.issn.1671-7554.0.2021.0199

Previous Articles     Next Articles

Identification of differentially expressed genes and Wilms tumor-1 expression in adenomyosis

GENG Chen, YANG Yang, ZHAO Yue, LIU Haoran, CHAO Lan   

  1. Center for Reproductive Medicine, Department of Obstetrics and Gynecology, Qilu Hospital, Cheeloo College of Medicine, Shandong University, Jinan 250012, Shandong, China
  • Published:2021-04-30

PDF (PC)

155

Abstract: Objective To screen the differentially expressed genes(DEGs)in adenomyosis from the Gene Expression Omnibus(GEO)database and to explore the expression of Wilms tumor-1(WT1). Methods The candidate genes were screened in the GEO database. The DEGs underwent Kyoto Encyclopedia of Genes and Genomes(KEGG)and Gene Ontology(GO)enrichment. The protein and mRNA expressions of WT1 in adenomyosis group and control group were detected with Western blotting and real-time quantitative polymerase chain reaction(qRT-PCR), respectively. The expression position and expression of WT1 in adenomyosis group and control group were determined with immunohistochemical staining. Results KEGG and GO of DEGs were enriched in transcription factor activity, cadherin binding involved in cell-cell adhesion, growth factor binding and other processes. Western blotting and qRT-PCR showed that the protein and mRNA expressions of WT1 were lower in the adenomyosis group than in the control group(P=0.002, P=0.003). Immunohistochemical staining showed that the WT1 staining level in stroma was lower in the adenomyosis group than in the control group(P=0.001), while the WT1 staining level in epithelium was higher(P<0.001); the overall staining level of WT1 in the adenomyosis group was lower than that in the control group(P=0.003). Conclusion The DEGs are screened from the GEO database and underwent KEGG and GO enrichment and WT1 may be involved in the pathogenesis of adenomyosis.

Key words: Adenomyosis, GEO data analysis, Differentially expressed genes, Enrichment analysis, Wilms tumor-1 gene

CLC Number: 

  • R711.71
[1] Soave I, Wenger JM, Pluchino N, et al. Treatment options and reproductive outcome for adenomyosis-associated infertility [J]. Curr Med Res Opin, 2018, 34(5): 839-849.
[2] Horton J, Sterrenburg M, Lane S, et al. Reproductive, obstetric, and perinatal outcomes of women with adenomyosis and endometriosis: a systematic review and meta-analysis [J]. Hum Reprod Update, 2019, 25(5): 592-632.
[3] Bourdon M, Oliveira J, Marcellin L, et al. Adenomyosis of the inner and outer myometrium are associated with different clinical profiles [J]. Hum Reprod, 2021, 36(2): 349-357.
[4] 中国医师协会妇产科医师分会子宫内膜异位症专业委员会. 子宫腺肌病诊治中国专家共识[J]. 中华妇产科杂志, 2020, 55(6): 376-383.
[5] Chapron C, Vannuccini S, Santulli P, et al. Diagnosing adenomyosis: an integrated clinical and imaging approach [J]. Hum Reprod Update, 2020, 26(3): 392-411.
[6] Upson K, Missmer SA. Epidemiology of adenomyosis [J]. Semin Reprod Med, 2020, 38(2-03): 89-107.
[7] Matsushima T, Akira S, Yoneyama K, et al. Recurrence of uterine adenomyosis after administration of gonadotropin-releasing hormone agonist and the efficacy of dienogest [J]. Gynecol Endocrinol, 2020, 36(6): 521-524.
[8] Hadley D, Pan J, El-Sayed O, et al. Precision annotation of digital samples in NCBIs gene expression omnibus [J]. Sci Data, 2017, 4(170125): 1-11.
[9] Dai FF, Bao AY, Luo B, et al. Identification of differentially expressed genes and signaling pathways involved in endometriosis by integrated bioinformatics analysis [J]. Exp Ther Med, 2020, 19(1): 264-272.
[10] Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets—update [J]. Nucleic Acids Res, 2013, 41(Database issue): D991-D995.
[11] Szklarczyk D, Morris JH, Cook H, et al. The STRING database in 2017: quality-controlled protein-protein association networks, made broadly accessible [J]. Nucleic Acids Res, 2017, 45(D1): D362-D368.
[12] Maere S, Heymans K, Kuiper M. BiNGO: a Cytoscape plugin to assess overrepresentation of gene ontology categories in biological networks [J]. Bioinformatics, 2005, 21(16): 3448-3449.
[13] Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: paths toward the comprehensive functional analysis of large gene lists [J]. Nucleic Acids Res, 2009, 37(1): 1-13.
[14] Benagiano G, Brosens I. The history of endometriosis: identifying the disease [J]. Hum Reprod, 1991, 6(7): 963-968.
[15] Kobayashi H, Kishi Y, Matsubara S. Mechanisms underlying adenomyosis-related fibrogenesis [J]. Gynecol Obstet Invest, 2020, 85(1):1-12.
[16] Carrarelli P, Yen CF, Funghi L, et al. Expression of inflammatory and neurogenic mediators in adenomyosis [J]. Reprod Sci, 2017, 24(3): 369-375.
[17] Xu W, Song Y, Li K, et al. Quercetin inhibits adenomyosis by attenuating cell proliferation, migration and invasion of ectopic endometrial stromal cells [J]. Drug Des Devel Ther, 2020, 14: 3815-3826.
[18] 林雪艳, 李春艳, 侯小满, 等. PARP-1及EMT标志物在子宫腺肌病在位及异位内膜中的表达[J]. 山东大学学报(医学版), 2017, 55(9):36-40. LIN Xueyan, LI Chunyan, HOU Xiaoman, et al. Expressions of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis [J]. Journal of Shandong university(Health Sciences), 2017, 55(9): 36-40.
[19] Pronier E, Bowman RL, Ahn J, et al. Genetic and epigenetic evolution as a contributor to WT1-mutant leukemogenesis [J]. Blood, 2018, 132(12): 1265-1278.
[20] Hung YP, Fletcher CD, Hornick JL. Evaluation of ETV4 and WT1 expression in CIC-rearranged sarcomas and histologic mimics [J]. Mod Pathol, 2016, 29(11): 1324-1334.
[21] Matsuzaki S, Canis M, Darcha C, et al. Expression of WT1 is down-regulated in eutopic endometrium obtained during the midsecretory phase from patients with endometriosis [J]. Fertil Steril, 2006, 86(3): 554-558.
[22] Bantounas I, Lopes FM, Rooney KM, et al. The miR-199a/214 cluster controls nephrogenesis and vascularization in a human embryonic stem cell model [J]. Stem Cell Reports, 2021, 16(1): 134-148.
[23] Zhang J, Tsoi H, Li X, et al. Carbonic anhydrase IV inhibits colon cancer development by inhibiting the Wnt signaling pathway through targeting the WTAP-WT1-TBL1 axis [J]. Gut, 2016, 65(9): 1482-1493.
[24] Han Y, Song C, Zhang T, et al. Wilms tumor 1(WT1)promotes ovarian cancer progression by regulating E-cadherin and ERK1/2 signaling [J]. Cell Cycle, 2020, 19(20): 2662-2675.
[25] Pishbin F, Ziamajidi N, Abbasalipourkabir R, et al. Correlation of miR-600 with WT1 expression and its potential clinical significance in breast cancer [J]. Per Med, 2021, 18(1): 31-42.
[26] Scharnhorst V, van der Eb AJ, Jochemsen AG. WT1 proteins: functions in growth and differentiation [J]. Gene, 2001, 273(2): 141-161.
[27] Lu B, Chen Q, Zhang X, et al. Serous carcinoma arising from uterine adenomyosis/adenomyotic cyst of the cervical stump: a report of 3 cases [J]. Diagn Pathol, 2016, 11(1): 46. doi: 10.1186/s13000-016-0496-0.
[28] Artibani M, Sims AH, Slight J, et al. WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel [J]. Sci Rep, 2017, 7(45255): 1-15.
[29] Makrigiannakis A, Coukos G, Mantani A, et al. Expression of Wilms Tumor Suppressor Gene(WT1)in Human Endometrium: Regulation through Decidual Differentiation [J]. J Clin Endocrinol Metab, 2001, 86(12): 5964-5972.
[30] Parenti R, Perris R, Vecchio GM, et al. Immunohistochemical expression of Wilms tumor protein(WT1)in developing human epithelial and mesenchymal tissues [J]. Acta Histochem, 2013, 115(1): 70-75.
[31] Nishikawa T, Wojciak JM, Dyson HJ, et al. RNA Binding by the KTS Splice Variants of Wilms Tumor Suppressor Protein WT1 [J]. Biochemistry, 2020, 59(40): 3889-3901.
[32] Schumacher V, Gueler B, Looijenga LH, et al. Characteristics of testicular dysgenesis syndrome and decreased expression of SRY and SOX9 in Frasier syndrome [J]. Mol Reprod Dev, 2008, 75(9): 1484-1494.
[1] Guoyun WANG,Zangyu PAN. Research progress of animal models of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 48-55.
[2] Lei YAN,Zijiang CHEN. Treatment of adenomyosis complicated with infertility [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 43-47.
[3] Guowei TAO,Fang WANG,Xiangyi DONG,Yaxuan XU,Linli ZHAO,Beibei HU. Diagnosis of adenomyosis using ultrasound and magnetic resonance imaging [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 56-65.
[4] AILI Aixingzi,Zhengyu GUO,Xiaofei ZHANG. Latest research advances of high intensity focused ultrasound treatment for adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 36-42.
[5] Xiaofang YI,Jihua HUANG. Patient education and proper management of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 32-35.
[6] Xinmei ZHANG,Ping XU. Surgical treatment strategies of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 26-31.
[7] Jinhua LENG,Jinghua SHI. Clinical manifestations of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 1-5.
[8] Chao PENG,Yingfang ZHOU. Progress on the medical treatment of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 20-25.
[9] Sunwei GUO,Xishi LIU. Cracking the enigma of pathogenesis and pathophysiology of adenomyosis [J]. Journal of Shandong University (Health Sciences), 2022, 60(7): 6-19.
[10] XU Ge, LI Qing, ZHANG Cancan, TIAN Yongjie. Expressions and clinical significance of PARP-1 and HIF-1α in adenomyosis tissues and primary cells [J]. Journal of Shandong University (Health Sciences), 2022, 60(4): 55-61.
[11] XIU Dejian, GAO Zhengwen, SONG Tingting, CUI Nan, CUI Jing, SUN Jianping. Genes associated with cervical cancer by integrated bioinformatics analysis [J]. Journal of Shandong University (Health Sciences), 2022, 60(10): 99-109.
[12] HUA Fang, ZHANG Weiwei, LYU Bo, XIN Wei. Bioinformatic analysis of genes and molecular pathways associated with osteoarthritis synovitis [J]. Journal of Shandong University (Health Sciences), 2021, 59(3): 10-17.
[13] WANG Bingyu, YANG Yang, CHAO Lan. Expression and role of toll-like receptor 4 in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2020, 58(6): 47-52.
[14] HUANG Yufei, YANG Yang, SHAO Qianqian, DENG Xiaohui, CHAO Lan. Expression and role of adenosine monophosphate dependent protein kinase in adenomyosis [J]. Journal of Shandong University (Health Sciences), 2019, 57(2): 93-98.
[15] LIN Xueyan, LI Chunyan, HOU Xiaoman, TIAN Yongjie. Expressions of PARP-1 and EMT markers in eutopic and ectopic endometrium of adenomyosis [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2017, 55(9): 36-40.
Viewed
Full text


Abstract

Cited
  Shared   
  Discussed   
[1] SUN Wei-peng,ZOU Wei-wei,XI Yan-wei,ZHANG Na. Oral absorption effect of liposomes with different sizes on TFu[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(6): 639 -642 .
[2] YU Qing-mei,WU Yu-ling,SONG Hai-yan,YIN Hua-wei,ZHUANG Yuan. Expression of p38 mitogen-activated protein kinase in early embryos and the peri-implantation endometrium in mice[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(2): 123 -127 .
[3] ZHANG Yong,YE Jing,GUO Xin-xing,XIAO Shui-qing. Immunohistochemical expression of IL-8 in pulpal tissues on orthodontic rapid tooth movement through distraction osteogenesis of the periodontal ligament[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(4): 379 -381 .
[4] XIAO Wei-ling,LIN Ya-jie,MU Dong-zhen,SUN Ping,LIANG Shu-juan. Recombinational expression of classical pathway secreted human IL-1β in hepatoma H7402 cells[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2008, 46(2): 119 -122 .
[5] GAO Jing,CHEN Wen,ZHANG Tong-xia,WANG Xiao-hua,DAI Ting-jun,YAO Hong,ZHAO Xiu-he,CHI Zhao-fu,SHAN Pei-yan. Changes of expression of mitochondrial cytochrome oxidase subunits Ⅲ and Ⅳ in the rat hippocampus of temporal lobe epilepsy[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(8): 817 -820 .
[6] . Expression and significance of stem cell marker LGR5 proteins in the  development  and progression of human colorectal carcinoma[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2009, 47(8): 85 -88 .
[7] YANG Kui-zhong,SUN Xue-fei,XIANG Ji-shun,DU Qing-cong,HUANG Feng-chang. Inhibitory effect of c-FLIP-ASODN on transplantation tumor of esophagus cancer cell line EC109 in nude mice: an experimental study[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(12): 1234 -1238 .
[8] YU Xin-shuang,HAN Jun-qing,WANG Xing-wen,SHENG Wei,WANG Yu. Relationship between cytoimmunologic status and prognosis of patients with breast cancer[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(9): 934 -937 .
[9] YU Yuan1, LI Yan1, RONG Fengnian2, LIANG Jing1, LIU Xiaolin1, WANG Fuli1. Therapy effect of auto-CIK on regulatory T cells in ovarian neoplasms patients[J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2010, 48(5): 101 -104 .
[10] . [J]. JOURNAL OF SHANDONG UNIVERSITY (HEALTH SCIENCES), 2007, 45(7): 751 -752 .
Copyright 2018 © Editorial office of Journal of Shandong University (Health Sciences)
Supported by Beijing Magtech Co.Ltd